✦ LIBER ✦

PCN6 PRESERVED ANTITUMOR ACTIVITY AND REDUCED CARDIOTOXICITY OF FIRST-LINE PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH CONVENTIONAL DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER

✍ Scribed by K Mann; C Rana; A Wadhwa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced cardiotoxicity and comparable ef

✍ O'Brien, M. E. R. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 949 KB

Pegylated Liposomal Doxorubicin and Cycl

✍ Beth Overmoyer; Paula Silverman; Larry W. Holder; Debasish Tripathy; I. Craig He 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 493 KB

First line therapy with paclitaxel (Taxo

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Liposome-encapsulated doxorubicin compar

✍ Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Noza 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Phase I/II study of gemcitabine with peg

✍ Zee-Wan Wong; Peter Cher-Siang Ang; Balram Chowbay; Nan-Soon Wong; Hui-Ti See; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

The clinical benefit of pegylated liposo

✍ Al-Batran, S-E; Bischoff, J; von Minckwitz, G; Atmaca, A; Kleeberg, U; Meuthen, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB